Cellular Biomedicine Group Inc (NASDAQ:CBMG)

39.22
Delayed Data
As of 10:47am ET
 +1.82 / +4.87%
Today’s Change
5.00
Today|||52-Week Range
49.00
+203.80%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$430.7M

Company Description

Cellular Biomedicine Group, Inc. is a biomedicine company. It engages in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The company's developmental stem cell, progenitor cell, and immune cell projects are the result of research and development by scientists and doctors from China and the United States. It operates in two segments: Biomedicine and Consulting. The Biomedicine segment is in development stage, conducting research and development activities to commercialize stem cell and immune cell therapeutics, related tools and products. The Consulting segment provides services to foreign and domestic companies seeking access to the U.S. capital markets. Cellular Biomedicine Group was founded in 2009 and is headquartered in Palo Alto, CA.

Contact Information

Cellular Biomedicine Group, Inc.
530 University Avenue
Palo Alto California 94301
P:(650) 566-5064
Investor Relations:

Employees

Shareholders

Other institutional2.88%
Individual stakeholders16.20%
Mutual fund holders0.37%

Top Executives

Wen Tao LiuChairman & President-North America
Wei CaoChief Executive Officer & Director
Bizuo LiuChief Financial Officer & Secretary
Maxwell WangDirector-Medical Research
Li ZhangVice President-Technology & Manufacturing

To view my watchlist

Not a member yet?

Sign up now for a free account